Divi's Laboratories Limited (BOM:532488)
India · Delayed Price · Currency is INR 6,551.80
-108.40 (-1.63%)
At close: Jun 1, 2026
Divi's Laboratories Revenue
In the fiscal year ending March 31, 2026, Divi's Laboratories had annual revenue of 105.60B INR with 12.82% growth. Divi's Laboratories had revenue of 28.31B in the quarter ending March 31, 2026, with 9.52% growth.
Revenue
105.60B
Revenue Growth
+12.82%
P/S Ratio
16.47
Revenue / Employee
10.02M
Employees
10,542
Market Cap
1.74T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 105.60B | 12.00B | 12.82% |
| Mar 31, 2025 | 93.60B | 15.15B | 19.31% |
| Mar 31, 2024 | 78.45B | 780.00M | 1.00% |
| Mar 31, 2023 | 77.67B | -11.93B | -13.31% |
| Mar 31, 2022 | 89.60B | 19.90B | 28.56% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 23.19B |
| Neuland Laboratories | 20.23B |
| Shilpa Medicare | 15.49B |
| Bajaj HealthCare | 6.11B |
| NGL Fine-Chem | 5.01B |
| Sai Parenteral's | 3.81B |
| Anlon Healthcare | 1.72B |
| Gujarat Themis Biosyn | 1.66B |
Divi's Laboratories News
- 7 days ago - Top stocks for trade today, May 25: Hindalco Industries, Torrent Pharma, Divi’s Lab, Eicher Motors, NTPC Green and more - Business Upturn
- 9 days ago - Divi's Laboratories Transcript: Q4 25/26 - Transcripts
- 9 days ago - Divi's Laboratories Quarterly report: Q4 2026 - Filings
- 9 days ago - Divi’s Laboratories Q4 Results: Net profit rises 13.4% YoY to Rs 751 crore, revenue up 9.5% - Business Upturn
- 9 days ago - Top Q4 results today, May 23: NTPC, Divi's Laboratories, JK Cement, Reliance Infrastructure among key companies to announce earnings - Business Upturn
- 2 months ago - Pharma sector stocks today, March 12: Divi's Laboratories down 1.87%, Abbott India drops 1.51%, Aarti Drugs falls 1.36% - Business Upturn
- 3 months ago - M&M, Lenskart & more: Stocks to watch out for today - The Times of India
- 3 months ago - Divi's Laboratories Transcript: Q3 25/26 - Transcripts